Navigation Links
ClearTrial Names Proven Enterprise Software and Life Sciences Sales Leader Craig Smith as Vice President of Sales
Date:10/13/2009

or helping life science companies streamline their clinical operations from plan to cash."

Smith's career demonstrates a consistent pattern of sales growth and leadership, with all of his sales teams establishing company records. At Documentum (now EMC), Smith was instrumental in building and leading the pharmaceutical industry vertical. During his tenure, Documentum became the pharmaceutical industry leader by providing high-value business applications that accelerated key business processes, responsive relationships with customers, and valued partner relationships. His sales and pre-sales organization consistently exceeded goals and grew revenue over tenfold in just four years by focusing on operational execution that placed the customer's requirements first.

At Saba Software, Smith built an enterprise sales team and grew North American sales eightfold to over $50M in two years through collaborative efforts with Saba customers and partners. During his tenure, Saba established the beginning of the enterprise-wide human capital management software market. As vice president of enterprise sales at iManage (Interwoven), Smith drove sales of the company's industry-leading collaboration products to enterprise customers.

"ClearTrial clinical trial operations software is a unique offering with real business value for an industry seeking ways to gain superior performance from their clinical operations," observed Smith. "ClearTrial has been embraced by customers for delivering greater efficiency while reducing costs, and providing senior executives with fast, accurate, and consistent visibility to their business. I'm looking forward to helping ClearTrial further improve its well-earned growth trajectory."

About ClearTrial®
ClearTrial is the leading provider of Clinical Trial Operations (CTO) software, a seamlessly integrated system for clinical operations planning, forecasting, outsourcing, and proj
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference
2. ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability
3. ClearTrial Names Software Industry Veteran Michael Bruns as Chief Operating Officer
4. ClearTrial to Chair Session at DIA 45th Annual Meeting on "Effective Operational Planning for Adaptive Clinical Trials"
5. ClearTrial Industry Expert to Lead Session at DIA Annual Meeting on Improving Accrual and Contract Management in Clinical Trials
6. ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference
7. ClearTrial Launches Industry-first Software Platform for Integrating Clinical Trial Operations from Plan to Cash™, Driving Operational Efficiencies and Accelerating Clinical Development
8. KGI Names Kerry Howell Vice President for Advancement
9. Vical Names Andrew de Guttadauro Vice President, Corporate Development
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... September 2, 2015 Biovista ... Wettbewerbs BeHEARD von 2015 bekanntgeben zu können. Hierbei ... Genomics Institute. Biovista unterstützt mit seiner ... die Behandlung anderer Krankheiten als denen, für die ... und sein Team bei der Wylder Nation ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... Staff members will be attending Pharma Ed Resources upcoming educational seminar and ... of industry leading speakers, this timely conference will provide Updates & Case Studies ...
(Date:9/2/2015)... ... September 02, 2015 , ... The TS5-Q ... professional commercial video content, to analysis of athletic performance. Producing high-resolution slow-motion ... by too quickly to process with the naked eye. , Slow motion ...
(Date:9/1/2015)... 2, 2015 Swecure, ... Forschung und Entwicklung neuartiger Therapien für Störungen ... und Reizdarm konzentriert, erhält vom US Patent ... neues Medikament patentiert wird. Das Medikament basiert ... Kindern verhindert und Entzündungen vorbeugt.   ...
Breaking Biology Technology:Biovista sponsert die Forschung von Wylder Nation Foundation zum Thema Mangel an saurer Sphingomyelinase 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3Das Patent von Swecure zur Verhinderung von Allergien bei Kindern wird in den USA zugelassen 2
... HARTFORD, Conn., Sept. 15 Genomas(R), a biomedical ... 3-year Phase II Small Business Innovation Research (SBIR) Grant totaling ... Disease, was awarded by the National Institute of Mental Health. ... Ruano, M.D., Ph.D., President/CEO of Genomas and Director of Genetics ...
... , , , ... (Nasdaq: PARD ) today announced that 320 evaluable events (patient ... Efficacy After Relapse) trial, which is being conducted in accordance with a ... evaluating picoplatin in the treatment of small cell lung cancer (SCLC). ...
... , , , ... today the launch of HemoRANK(TM)-TKI, an in vitro assay service ... kinase inhibitors (TKIs) to cause clinical hematotoxicity (myelotoxicity or neutropenia). ... pharmaceutical companies that are developing novel therapeutic TKIs gain insight ...
Cached Biology Technology:Genomas Awarded $1.4 Million NIH SBIR Grant to Develop MRI+DNA Guided Biomarker System for Mental Illness 2Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 2Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 3Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 4Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 5ReachBio Launches HemoRANK-TKI Service Package for Predicting Myelotoxicity of New Tyrosine Kinase Inhibitors 2ReachBio Launches HemoRANK-TKI Service Package for Predicting Myelotoxicity of New Tyrosine Kinase Inhibitors 3
(Date:8/10/2015)... BOSTON and TELTOW, Germany ... SensoMotoric Instruments (SMI), a world leader in Eye ... the completion of its OEM Eye Tracking Platform for ... Eye Tracking Platform contains reference designs for seamless integration ... kiosk systems, virtual reality HMDs and augmented reality smart ...
(Date:8/6/2015)... 6, 2015  Today, U.S. Congressman Mike ... ™ to learn firsthand how Silicon Valley technologies ... is a world leader in multi-factor identity management ... helping federal agencies and commercial organizations achieve new ... "The vast majority of network breaches can ...
(Date:8/6/2015)... , Aug. 6, 2015 Synaptics ... of human interface solutions, today announced collaboration with ... on Windows 10. Microsoft leveraged Synaptics, deep expertise ... operating system. Through stringent testing, ... fully certified with Microsoft,s Precision TouchPad (PTP) specification ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Rep. Honda to Visit Crossmatch in Redwood City 2Synaptics Chosen for Human Interface Co-Development on Windows 10 2
... Today a plethora of dog genome-related materials are published, including ... and a series of primary research articles in the ... the publication by Nature of a high-quality draft ... researchers and the public with informative resources about canine genomics ...
... by Duke computer scientists and computational chemists have ... in an intricate three-dimensional puzzle-fit to regulate cell ... anticancer drugs to block the runaway cell division ... Significantly, their insights arose not just from meticulous ...
... scientists who first created "mighty mice" have developed, with ... agent that's more effective at increasing muscle mass in ... now in clinical trials. , The new agent is ... muscle-limiting protein myostatin. In mice, just two weekly injections ...
Cached Biology News:Scientists fetch useful information from dog genome publications 2Scientists fetch useful information from dog genome publications 3Scientists fetch useful information from dog genome publications 4'Computer-chemistry' yields new insight into a puzzle of cell division 2'Computer-chemistry' yields new insight into a puzzle of cell division 3'Computer-chemistry' yields new insight into a puzzle of cell division 4Mouse study: New muscle-building agent beats all previous ones 2
Request Info...
... Calmodulin Sepharose 4B, ... single-step purification of ... proteins.Purification of calmodulin-regulated ... eukaryotic cells. Category: ...
...
AdestaTM Tissue/Cell Preservation Medium Sterile / Non-sterile: Sterility Tested Endotoxin: ...
Biology Products: